Research progress of RNA m6A methylation in post-stroke cognitive impairment

doi:10.11958/20230780

Abstract

Abstract:

Post-stroke cognitive impairment (PSCI) is mainly manifested as learning and memory disorders. Highly enriched RNA m6A methylation modification in mammalian brain is involved in glial cell-mediated neuroinflammation. Given that neuroinflammation is the main mechanism for neural damage and spatial and memory impairment of PSCI, it is speculated that RNA m6A methylation modification can regulate the inflammatory response of glial cells after stroke to improve PSCI. This review summarizes and analyzes the role of RNA m6A methylation modification in the development of PSCI and analyzes its detailed mechanism of regulating glial cell-mediated inflammation, which will provide reference for researchers in this field.

Key words: stroke, cognition disorders, inflammation, microglia, astrocytes, m6A methylation

CLC Number:

R743.3

Figures/Tables 1

References 49

[1]	LEE K P, CHANG A Y W, SUNG P S. Association between blood pressure,blood pressure variability,and post-stroke cognitive impairment[J]. Biomedicines, 2021, 9(7):773. doi:10.3390/biomedicines9070773.
[2]	RAN Y, SU W, GAO F, et al. Curcumin ameliorates white matter injury after ischemic stroke by inhibiting microglia/macrophage pyroptosis through NF-κB suppression and NLRP3 inflammasome inhibition[J]. Oxid Med Cell Longev, 2021, 2021:1552127. doi:10.1155/2021/1552127.
[3]	LI Q, WEN S, YE W, et al. The potential roles of m6A modification in regulating the inflammatory response in microglia[J]. J Neuroinflammation, 2021, 18(1):149. doi:10.1186/s12974-021-02205-z.
[4]	ZACCARA S, RIES R J, JAFFREY S R. Reading,writing and erasing mRNA methylation[J]. Nat Rev Mol Cell Biol, 2019, 20(10):608-624. doi:10.1038/s41580-019-0168-5.
[5]	YU Z, ZHENG L, GENG Y, et al. FTO alleviates cerebral ischemia/reperfusion-induced neuroinflammation by decreasing cGAS mRNA stability in an m6A-dependent manner[J]. Cell Signal, 2023, 109:110751. doi:10.1016/j.cellsig.2023.110751.
[6]	SCHÖLLER E, WEICHMANN F, TREIBER T, et al. Interactions,localization,and phosphorylation of the m6A generating METTL3-METTL14-WTAP complex[J]. RNA, 2018, 24(4):499-512. doi:10.1261/rna.064063.117.
[7]	AOYAMA T, YAMASHITA S, TOMITA K. Mechanistic insights into m6A modification of U6 snRNA by human METTL16[J]. Nucleic Acids Res, 2020, 48(9):5157-5168. doi:10.1093/nar/gkaa227.
[8]	ZOU J, LIU H, TAN W, et al. Dynamic regulation and key roles of ribonucleic acid methylation[J]. Front Cell Neurosci, 2022, 16:1058083. doi:10.3389/fncel.2022.1058083.
[9]	SPYCHALA A, RÜTHER U. FTO affects hippocampal function by regulation of BDNF processing[J]. PloS One, 2019, 14(2):e0211937. doi:10.1371/journal.pone.0211937.
[10]	DU T, LI G, YANG J, et al. RNA demethylase Alkbh5 is widely expressed in neurons and decreased during brain development[J]. Brain Res Bull, 2020, 163:150-159. doi:10.1016/j.brainresbull.2020.07.018.
[11]	SHI R, YING S, LI Y, et al. Linking the YTH domain to cancer:the importance of YTH family proteins in epigenetics[J]. Cell Death Dis, 2021, 12(4):346. doi:10.1038/s41419-021-03625-8.
[12]	SUN C Y, CAO D, DU B B, et al. The role of insulin-like growth factor 2 mRNA-binding proteins(IGF2BPs)as m(6)A readers in cancer[J]. Int J Biol Sci, 2022, 18(7):2744-2758. doi:10.7150/ijbs.70458.
[13]	CHOE J, LIN S, ZHANG W, et al. mRNA circularization by METTL3-eIF3h enhances translation and promotes oncogenesis[J]. Nature, 2018, 561(7724):556-560. doi:10.1038/s41586-018-0538-8.
[14]	LI X, AN P, HAN F, et al. Silencing of YTHDF1 attenuates cerebral stroke by inducing PTEN degradation and activating the PTEN/AKT/mTOR pathway[J]. Mol Biotechnol, 2022, 65(5):822-832. doi:10.1007/s12033-022-00575-0.
[15]	SI W, LI Y, YE S, et al. Methyltransferase 3 mediated miRNA m6A methylation promotes stress granule formation in the early stage of acute ischemic stroke[J]. Front Mol Neurosci, 2020, 13:103. doi:10.3389/fnmol.2020.00103.
[16]	LIU Y, YAN Z, REN Y, et al. Electroacupuncture inhibits hippocampal neuronal apoptosis and improves cognitive dysfunction in mice with vascular dementia via the JNK signaling pathway[J]. Acupunct Med, 2022:9645284221136878. doi:10.1177/09645284221136878.
[17]	XU K, MO Y, LI D, et al. N(6)-methyladenosine demethylases Alkbh5/Fto regulate cerebral ischemia-reperfusion injury[J]. Ther Adv Chronic Dis, 2020, 11:2040622320916024. doi:10.1177/2040622320916024.
[18]	HOU L, LI S, LI S, et al. FTO inhibits oxidative stress by mediating m6A demethylation of Nrf2 to alleviate cerebral ischemia/reperfusion injury[J]. J Physiol Biochem, 2023, 79(1):133-146. doi:10.1007/s13105-022-00929-x.
[19]	WANG Q S, XIAO R J, PENG J, et al. Bone marrow mesenchymal stem cell-derived exosomal KLF4 alleviated ischemic stroke through inhibiting N6-Methyladenosine modification level of Drp1 by targeting lncRNA-ZFAS1[J]. Mol Neurobiol, 2023, 60(7):3945-3962. doi:10.1007/s12035-023-03301-2.
[20]	LI L, ZANG L, ZHANG F, et al. Fat mass and obesity-associated(FTO)protein regulates adult neurogenesis[J]. Hum Mol Genet, 2017, 26(13):2398-2411. doi:10.1093/hmg/ddx128.
[21]	ZHUANG M, LI X, ZHU J, et al. The m6A reader YTHDF1 regulates axon guidance through translational control of Robo3.1 expression[J]. Nucleic Acids Res, 2019, 47(9):4765-4777. doi:10.1093/nar/gkz157.
[22]	SHI H, ZHANG X, WENG Y L, et al. m(6)A facilitates hippocampus-dependent learning and memory through YTHDF1[J]. Nature, 2018, 563(7730):249-253. doi:10.1038/s41586-018-0666-1.
[23]	CHEN J, ZHANG Y C, HUANG C, et al.m(6)A regulates neurogenesis and neuronal development by modulating histone methyltransferase Ezh2[J]. Genomics Proteomics Bioinformatics, 2019, 17(2):154-168. doi:10.1016/j.gpb.2018.12.007.
[24]	XU S, LI Y, CHEN J P, et al. Oxygen glucose deprivation/re-oxygenation-induced neuronal cell death is associated with Lnc-D63785 m6A methylation and miR-422a accumulation[J]. Cell Death Dis, 2020, 11(9):816. doi:10.1038/s41419-020-03021-8.
[25]	SUN P, MA F, XU Y, et al. Genetic deletion of endothelial microRNA-15a/16-1 promotes cerebral angiogenesis and neurological recovery in ischemic stroke through Src signaling pathway[J]. J Cereb Blood Flow Metab, 2021, 41(10):2725-2742. doi:10.1177/0271678x211010351.
[26]	MATHIYALAGAN P, ADAMIAK M, MAYOURIAN J, et al.FTO-dependent N(6)-methyladenosine regulates cardiac function during remodeling and repair[J]. Circulation, 2019, 139(4):518-532. doi:10.1161/circulationaha.118.033794.
[27]	YAO M D, JIANG Q, MA Y, et al. Role of METTL3-dependent N(6)-methyladenosine mRNA modification in the promotion of angiogenesis[J]. Mol Ther, 2020, 28(10):2191-2202. doi:10.1016/j.ymthe.2020.07.022.
[28]	LI B, XI W, BAI Y, et al.FTO-dependent m(6)A modification of Plpp3 in circSCMH1-regulated vascular repair and functional recovery following stroke[J]. Nat Commun, 2023, 14(1):489. doi:10.1038/s41467-023-36008-y.
[29]	LIANG E, XIAO S, ZHAO C, et al. M6A modification promotes blood-brain barrier breakdown during cerebral ischemia/reperfusion injury through increasing matrix metalloproteinase 3 expression[J]. Heliyon, 2023, 9(6):e16905. doi:10.1016/j.heliyon.2023.e16905.
[30]	LI S, HU W, GONG S, et al. The role of PRRC2B in cerebral vascular remodeling under acute hypoxia in mice[J]. Adv Sci(Weinh), 2023:e2300892. doi:10.1002/advs.202300892.
[31]	ZHANG X, YUAN M, YANG S, et al. Enriched environment improves post-stroke cognitive impairment and inhibits neuroinflammation and oxidative stress by activating Nrf2-ARE pathway[J]. Int J Neurosci, 2021, 131(7):641-649. doi:10.1080/00207454.2020.1797722.
[32]	ZHU L, LIU S, LIAO F, et al. Comprehensive analysis of blood-based m6A methylation in human ischemic stroke[J]. Mol Neurobiol, 2023, 60(2):431-446. doi:10.1007/s12035-022-03064-2.
[33]	CHOKKALLA A K, MEHTA S L, KIM T, et al. Transient focal ischemia significantly alters the m(6)A epitranscriptomic tagging of RNAs in the brain[J]. Stroke, 2019, 50(10):2912-2921. doi:10.1161/strokeaha.119.026433.
[34]	HOSHINO K, HASEGAWA K, KAMIYA H, et al. Synapse-specific effects of IL-1β on long-term potentiation in the mouse hippocampus[J]. Biomed Res, 2017, 38(3):183-188. doi:10.2220/biomedres.38.183.
[35]	AL MAMUN A, CHAUHAN A, QI S, et al. Microglial IRF5-IRF4 regulatory axis regulates neuroinflammation after cerebral ischemia and impacts stroke outcomes[J]. Proc Natl Acad Sci U S A, 2020, 117(3):1742-1752. doi:10.1073/pnas.1914742117.
[36]	WEN L, SUN W, XIA D, et al. The m6A methyltransferase METTL3 promotes LPS-induced microglia inflammation through TRAF6/NF-κB pathway[J]. Neuroreport, 2022, 33(6):243-251. doi:10.1097/wnr.0000000000001550.
[37]	DING L, WU H, WANG Y, et al. m6A reader Igf2bp1 regulates the inflammatory responses of microglia by stabilizing Gbp11 and Cp mRNAs[J]. Front Immunol, 2022, 13:872252. doi:10.3389/fimmu.2022.872252.
[38]	ZHOU H, XU Z, LIAO X, et al. Low expression of YTH domain-containing 1 promotes microglial M1 polarization by reducing the stability of sirtuin 1 mRNA[J]. Front Cell Neurosci, 2021, 15:774305. doi:10.3389/fncel.2021.774305.
[39]	ZHENG L, TANG X, LU M, et al. microRNA-421-3p prevents inflammatory response in cerebral ischemia/reperfusion injury through targeting m6A reader YTHDF1 to inhibit p65 mRNA translation[J]. Int Immunopharmacol, 2020, 88:106937. doi:10.1016/j.intimp.2020.106937.
[40]	TAN C, WU Q, WANG H, et al. Dysbiosis of gut microbiota and short-chain fatty acids in acute ischemic stroke and the subsequent risk for poor functional outcomes[J]. JPEN J Parenter Enteral Nutr, 2021, 45(3):518-529. doi:10.1002/jpen.1861.
[41]	LIAO S, WU J, LIU R, et al. A novel compound DBZ ameliorates neuroinflammation in LPS-stimulated microglia and ischemic stroke rats: role of Akt(Ser473)/GSK3β(Ser9)-mediated Nrf2 activation[J]. Redox Biol, 2020, 36:101644. doi:10.1016/j.redox.2020.101644.
[42]	QI L, HU H, WANG Y, et al. New insights into the central sympathetic hyperactivity post-myocardial infarction: roles of METTL3-mediated m(6)A methylation[J]. J Cell Mol Med, 2022, 26(4):1264-1280. doi:10.1111/jcmm.17183.
[43]	HU W, XIE H, ZENG Y, et al. N6-methyladenosine participates in mouse hippocampus neurodegeneration via PD-1/PD-L1 pathway[J]. Front Neurosci, 2023, 17:1145092. doi:10.3389/fnins.2023.1145092.
[44]	JIANG Z, SHI L, HUANG H, et al. Downregulated FTO promotes microRNA-155-mediated inflammatory response in cerebral ischemia/reperfusion injury[J]. Neuroscience, 2023: 526:305-313. doi:10.1016/j.neuroscience.2023.07.012.
[45]	LIU Q, BHUIYAN M I H, LIU R, et al. Attenuating vascular stenosis-induced astrogliosis preserves white matter integrity and cognitive function[J]. J Neuroinflammation, 2021, 18(1):187. doi:10.1186/s12974-021-02234-8.
[46]	COCKOVA Z, HONC O, TELENSKY P, et al. Streptozotocin-induced astrocyte mitochondrial dysfunction is ameliorated by FTO inhibitor MO-I-500[J]. ACS Chem Neurosci, 2021, 12(20):3818-3828. doi:10.1021/acschemneuro.1c00063.
[47]	HUANG R, ZHANG Y, BAI Y, et al. N(6)-methyladenosine modification of fatty acid amide hydrolase messenger RNA in circular RNA STAG1-regulated astrocyte dysfunction and depressive-like behaviors[J]. Biol Psychiatry, 2020, 88(5):392-404. doi:10.1016/j.biopsych.2020.02.018.
[48]	LI Z, MONIRUZZAMAN M, DASTGHEYB R M, et al. Astrocytes deliver CK1 to neurons via extracellular vesicles in response to inflammation promoting the translation and amyloidogenic processing of APP[J]. J Extracell Vesicles, 2020, 10(2):e12035. doi:10.1002/jev2.12035.
[49]	OUYANG F, JIANG Z, CHEN X, et al. Is cerebral amyloid-β deposition related to post-stroke cognitive impairment?[J]. Transl Stroke Res, 2021, 12(6):946-957. doi:10.1007/s12975-021-00921-5.